Trial
NCT02531308
Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
—
Condition
Diffuse Large B-Cell Lymphoma
Intervention
Metformin
Why stopped
poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-28